Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitReceivables - NetReceivables - OtherShares OutstandingShares OutstandingShort-Term Debt repayments
Ratios

Medicure (MCUJF) Receivables - Other (2016 - 2025)

Medicure has reported Receivables - Other over the past 10 years, most recently at $68123.2 for Q4 2025.

  • For Q4 2025, Receivables - Other rose 171.9% year-over-year to $68123.2; the TTM value through Dec 2025 reached $68123.2, up 171.9%, while the annual FY2025 figure was $68123.2, 171.9% up from the prior year.
  • Receivables - Other for Q4 2025 was $68123.2 at Medicure, up from $25054.7 in the prior quarter.
  • Over five years, Receivables - Other peaked at $270309.1 in Q4 2023 and troughed at $25054.7 in Q4 2024.
  • A 5-year average of $99376.9 and a median of $68123.2 in 2025 define the central range for Receivables - Other.
  • Biggest five-year swings in Receivables - Other: soared 233.56% in 2023 and later plummeted 90.73% in 2024.
  • Year by year, Receivables - Other stood at $52360.2 in 2021, then skyrocketed by 54.77% to $81037.3 in 2022, then soared by 233.56% to $270309.1 in 2023, then plummeted by 90.73% to $25054.7 in 2024, then soared by 171.9% to $68123.2 in 2025.
  • Business Quant data shows Receivables - Other for MCUJF at $68123.2 in Q4 2025, $25054.7 in Q4 2024, and $270309.1 in Q4 2023.